219 related articles for article (PubMed ID: 7925100)
1. Correlation between suppression of c-myc and antiproliferative effect of transforming growth factor-beta 1 in thyroid carcinoma cell growth.
Usa T; Tsukazaki T; Namba H; Ohtsuru A; Kimura H; Villadolid MC; Nagataki S; Yamashita S
Endocrinology; 1994 Oct; 135(4):1378-84. PubMed ID: 7925100
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor-beta 1 induces growth inhibition of a human medullary thyroid carcinoma cell line despite an increase in steady state c-myc messenger ribonucleic acid levels.
Khosla S; Oursler MJ; Schroeder MJ; Eberhardt NL
Endocrinology; 1994 Nov; 135(5):1887-93. PubMed ID: 7956909
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-1 inhibits human thyroid carcinoma cell growth.
Kimura H; Yamashita S; Namba H; Tominaga T; Tsuruta M; Yokoyama N; Izumi M; Nagataki S
J Clin Endocrinol Metab; 1992 Aug; 75(2):596-602. PubMed ID: 1322431
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor-beta negatively modulates proliferation and c-fos expression of the human endometrial adenocarcinoma cell line HEC-1-A.
Bergman CA; Talavera F; Christman GM; Baker VV; Roberts JA; Menon KM
Gynecol Oncol; 1997 Apr; 65(1):63-8. PubMed ID: 9103392
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-beta 1 induces apoptosis through down-regulation of c-myc gene and overexpression of p27Kip1 protein in cervical carcinoma.
Kim JW; Kim HS; Kim IK; Kim MR; Cho EY; Kim HK; Lee JM; Namkoong SE
Gynecol Oncol; 1998 Jun; 69(3):230-6. PubMed ID: 9648593
[TBL] [Abstract][Full Text] [Related]
6. Effect of 22-oxa-1,25-dihydroxyvitamin D3 on human thyroid cancer cell growth.
Okano K; Usa T; Ohtsuru A; Tsukazaki T; Miyazaki Y; Yonekura A; Namba H; Shindoh H; Yamashita S
Endocr J; 1999 Apr; 46(2):243-52. PubMed ID: 10460008
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor beta 1 suppression of c-myc gene transcription: role in inhibition of keratinocyte proliferation.
Pietenpol JA; Holt JT; Stein RW; Moses HL
Proc Natl Acad Sci U S A; 1990 May; 87(10):3758-62. PubMed ID: 2187192
[TBL] [Abstract][Full Text] [Related]
8. TGF beta regulation of epithelial cell proliferation: role of tumor suppressor genes.
Moses HL; Pietenpol JA; Münger K; Murphy CS; Yang EY
Princess Takamatsu Symp; 1991; 22():183-95. PubMed ID: 1844240
[TBL] [Abstract][Full Text] [Related]
9. TNF-alpha-induced antiproliferation is not dependent on the autocrine action of TGF-beta 1 in a thyroid cancer cell line.
Pang XP; Yoshimura M; Wang J; Dubinett SM
Lymphokine Cytokine Res; 1994 Apr; 13(2):93-7. PubMed ID: 8061120
[TBL] [Abstract][Full Text] [Related]
10. Antisense targeting of c-fos transcripts inhibits serum- and TGF-beta 1-stimulated PAI-1 gene expression and directed motility in renal epithelial cells.
Kutz SM; Providence KM; Higgins PJ
Cell Motil Cytoskeleton; 2001 Mar; 48(3):163-74. PubMed ID: 11223948
[TBL] [Abstract][Full Text] [Related]
11. Factor-binding element in the human c-myc promoter involved in transcriptional regulation by transforming growth factor beta 1 and by the retinoblastoma gene product.
Pietenpol JA; Münger K; Howley PM; Stein RW; Moses HL
Proc Natl Acad Sci U S A; 1991 Nov; 88(22):10227-31. PubMed ID: 1946442
[TBL] [Abstract][Full Text] [Related]
12. Colon cancer cells that are not growth inhibited by TGF-beta lack functional type I and type II TGF-beta receptors.
MacKay SL; Yaswen LR; Tarnuzzer RW; Moldawer LL; Bland KI; Copeland EM; Schultz GS
Ann Surg; 1995 Jun; 221(6):767-76; discussion 776-7. PubMed ID: 7794080
[TBL] [Abstract][Full Text] [Related]
13. Differential dependence of the tumorigenicity of chemically transformed rat liver epithelial cells on autocrine production of transforming growth factor alpha.
Duddy SK; Earp HS; Russell WE; Smith GJ; Grisham JW
Cell Growth Differ; 1995 Mar; 6(3):251-61. PubMed ID: 7794793
[TBL] [Abstract][Full Text] [Related]
14. Glucocorticoids coordinately regulate type I collagen pro alpha 1 promoter activity through both the glucocorticoid and transforming growth factor beta response elements: a novel mechanism of glucocorticoid regulation of eukaryotic genes.
Meisler N; Shull S; Xie R; Long GL; Absher M; Connolly JP; Cutroneo KR
J Cell Biochem; 1995 Nov; 59(3):376-88. PubMed ID: 8567755
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor beta 1 can induce CIP1/WAF1 expression independent of the p53 pathway in ovarian cancer cells.
Elbendary A; Berchuck A; Davis P; Havrilesky L; Bast RC; Iglehart JD; Marks JR
Cell Growth Differ; 1994 Dec; 5(12):1301-7. PubMed ID: 7696178
[TBL] [Abstract][Full Text] [Related]
16. Loss of transforming growth factor beta 1 receptors and its effects on the growth of EBV-transformed human B cells.
Kumar A; Rogers T; Maizel A; Sharma S
J Immunol; 1991 Aug; 147(3):998-1006. PubMed ID: 1713611
[TBL] [Abstract][Full Text] [Related]
17. Sensitivity to transforming growth factor beta 1-induced growth arrest is common in human squamous cell carcinoma cell lines: c-MYC down-regulation and p21waf1 induction are important early events.
Malliri A; Yeudall WA; Nikolic M; Crouch DH; Parkinson EK; Ozanne B
Cell Growth Differ; 1996 Oct; 7(10):1291-304. PubMed ID: 8891333
[TBL] [Abstract][Full Text] [Related]
18. Expression of transforming growth factor-beta1 and transforming growth factor-beta Type-II receptor mRNA in papillary thyroid carcinoma.
Matoba H; Sugano S; Yamaguchi N; Miyachi Y
Horm Metab Res; 1998 Oct; 30(10):624-8. PubMed ID: 9851670
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor-beta1 and activin A generate antiproliferative signaling in thyroid cancer cells.
Matsuo SE; Leoni SG; Colquhoun A; Kimura ET
J Endocrinol; 2006 Jul; 190(1):141-50. PubMed ID: 16837618
[TBL] [Abstract][Full Text] [Related]
20. Antitumor actions of cytokines on new human papillary thyroid carcinoma cell lines.
Ohta K; Pang XP; Berg L; Hershman JM
J Clin Endocrinol Metab; 1996 Jul; 81(7):2607-12. PubMed ID: 8675585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
